With trial results in infants, Merck advances next-gen pneumococcal shot Vaxneuvance in race against Pfizernews2021-08-25T13:22:26+00:00August 25th, 2021|Fierce Pharma|
Johnson & Johnson touts antibody response for COVID-19 booster 8 months after original vaccinationnews2021-08-25T13:13:33+00:00August 25th, 2021|Fierce Pharma|
GSK propels ‘Our Way Forward’ ovarian cancer campaign, doubling down on patient stories during the pandemicnews2021-08-25T13:07:33+00:00August 25th, 2021|Fierce Pharma|
Sanofi, GSK and Seqirus prep for near-record flu shot sales as COVID’s delta variant cooks up ‘recipe for disaster’news2021-08-24T22:10:16+00:00August 24th, 2021|Fierce Pharma|
Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER saysnews2021-08-24T18:26:49+00:00August 24th, 2021|Fierce Pharma|
J&J, Bayer’s Xarelto scores FDA nod in post-surgery artery disease as partners try to catch up with Eliquisnews2021-08-24T15:31:29+00:00August 24th, 2021|Fierce Pharma|
Manufacturing issues force delay for PolarityTE’s skin repair hopefulnews2021-08-24T15:17:00+00:00August 24th, 2021|Fierce Pharma|
Regeneron’s bid for high-dose Eylea scores early win, but the ‘all important’ data are still to come: analystsnews2021-08-24T15:15:55+00:00August 24th, 2021|Fierce Pharma|
Pharma’s reputation drops again. Could it foreshadow a return to the bottom?news2021-08-24T14:44:24+00:00August 24th, 2021|Fierce Pharma|
Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and morenews2021-08-24T13:21:27+00:00August 24th, 2021|Fierce Pharma|
